Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans

Gibson, 2003, Pathophysiology and management of pulmonary infections in cystic fibrosis, Am J Respir Crit Care, 168, 918, 10.1164/rccm.200304-505SO

Steinkamp, 2005, Prospective evaluation of emerging bacteria in cystic fibrosis, J Cyst Fibros, 4, 41, 10.1016/j.jcf.2004.10.002

Ryley, 2004, Burkholderia cepacia complex infection in cystic fibrosis patients: mechanisms of pathogenesis, Rev Med Microbiol, 15, 93, 10.1097/00013542-200407000-00002

Mahenthiralingam, 2005, The multifarious, multireplicon Burkholderia cepacia complex, Nat Rev Microbiol, 3, 144, 10.1038/nrmicro1085

Li Puma, 2001, Disproportionate distribution of Burkholderia cepacia complex species and transmissibility factors in cystic fibrosis, Am J Respir Crit Care Med, 164, 92, 10.1164/ajrccm.164.1.2011153

Li Puma, 1990, Person to person transmission of Pseudomonas cepacia between persons with cystic fibrosis, Lancet, 336, 1094, 10.1016/0140-6736(90)92571-X

Biddick, 2003, Evidence of transmission of Burkholderia cenocepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis, FEMS Microbiol Lett, 228, 57, 10.1016/S0378-1097(03)00724-9

Kalish, 2006, Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis, Am J Respir Crit Care Med, 173, 421, 10.1164/rccm.200503-344OC

Cieri, 2002, Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection, Infect Immun, 70, 1081, 10.1128/IAI.70.3.1081-1086.2002

Conway, 2002, Biofilm formation and acylhomoserine lactone production in the Burkholderia cepacia complex, J Bacteriol, 184, 5678, 10.1128/JB.184.20.5678-5685.2002

Desai, 1990, Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia, J Antimicrob Chemother, 42, 152

Coeyne, 2003, An updated version of the Burkholderia cepacia complex experimental strain panel, J Clin Microbiol, 41, 2797, 10.1128/JCM.41.6.2797-2798.2003

Mahenthiralingam, 2000, Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex, J Clin Microbiol, 38, 910, 10.1128/JCM.38.2.910-913.2000

Marshall, 1996, J Clin Microbiol, 34, 2027, 10.1128/JCM.34.8.2027-2029.1996

Ge, 1999, In vitro antibacterial properties of Poxiganan, an analog of Magainin, Antimicrob Agents Chemother, 43, 782, 10.1128/AAC.43.4.782

Martin, 2000, Invasion and intracellular survival of Burkholderia cepacia, Infect Immun, 68, 24, 10.1128/IAI.68.1.24-29.2000

Toole, 1998, Initiation of biofilm formation in Pseudomonas fluorescens WCS 365 proceeds via multiple convergent signalling pathways: a genetic analysis, Mol Microbiol, 28, 449, 10.1046/j.1365-2958.1998.00797.x

Vermis, 2003, Burkholderia cepacia complex genomovars: utilisation of carbon sources, susceptibility to antimicrobial agents and growth on selective media, J Appl Microbiol, 95, 1191, 10.1046/j.1365-2672.2003.02054.x

Saini, 1999, Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation, Microbiology, 145, 3465, 10.1099/00221287-145-12-3465

Caraher E, Reynolds G, Murphy P, McClean S, Callaghan M, Comparison of Burkholderia cepacia complex (Bcc) strains susceptibility to antibiotics when grown planktonically or as a biofilm in vitro. J Antimicrob Chemother sumitted for publication.

Cunha, 2004, Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections, J Clin Microbiol, 42, 3052, 10.1128/JCM.42.7.3052-3058.2004